Skip to main content
Clinical Trials/NCT03571659
NCT03571659CompletedNot Applicable

To Assess the Safety and Efficacy of Two Subthreshold Parameters (5% and 15% Duty Cycle (DC)) Compared to Standard ETDRS (Early Treatment of Diabetic Retinopathy Study) Continuous Wave (CW) Laser

L.V. Prasad Eye Institute0 sites32 target enrollmentStarted: December 22, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
32
Primary Endpoint
1. Decrease in number of leaking Mas on FFA 2. Decrease in diffuse leakage on FFA

Study Overview

Brief Summary

To assess the safety and efficacy of two subthreshold parameters (5% and 15% duty cycle (DC)) compared to standard ETDRS (early treatment of diabetic retinopathy study) continuous wave (CW) laser

Detailed Description

Test burn up to barely visible burn with micropulse laser, then reduce the power by 70% and perform laser with various DC (5%, 15%, cw) as per the group.

Focal to Mas+ confluent burns to areas of diffuse leakage

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Eyes with DME (center or non-center involving) with <350 microns central retinal thickness

Exclusion Criteria

  • Subfoveal exudates, history of VR surgery, history of macular laser

Outcomes

Primary Outcomes

1. Decrease in number of leaking Mas on FFA 2. Decrease in diffuse leakage on FFA

Time Frame: 3 months

Comparing the number of leaking microaneuyrms baseline to 6 weeks with 3 types of lasers (two subthreshold parameters (5% and 15% duty cycle (DC)) compared to standard ETDRS continuous wave (CW) laser.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr Jay Chhablani

Principal Investigator

L.V. Prasad Eye Institute

Similar Trials